CenterBook Partners’s Anterix ATEX Stock Holding History
Bought
Maintained
Sold
Other funds holding ATEX
CenterBook Partners's ATEX Position: Q3 2026 in Review
CenterBook Partners increased its Anterix (ATEX) stake by 165% in Q3 2026, buying an estimated $1.05M and bringing the position to 18,242 shares worth $1.43M. The position accounts for 0.07% of the portfolio, ranked #367.
CenterBook Partners first reported a position in ATEX in Q4 2021 and has held it in 13 quarters since. The position peaked at $4.88M in Q1 2026. 38 funds tracked by Wall St. Rank hold ATEX as of Q3 2026.
- CenterBook Partners held 18,242 shares of Anterix worth $1.43M as of Q3 2026.
- CenterBook Partners bought 11,365 Anterix shares in Q3 2026, an estimated $1.05M.
- Anterix made up 0.07% of CenterBook Partners's portfolio in Q3 2026, its #367 holding.
- CenterBook Partners first reported a position in Anterix in Q4 2021 and has held it in 13 quarters since.
- CenterBook Partners's Anterix position peaked at $4.88M in Q1 2026.
- 38 funds tracked by Wall St. Rank held Anterix as of Q3 2026.
Based on CenterBook Partners's 13F filing for Q3 2026, filed 2 Nov 2026.